Why Veeco Instruments (VECO) Is Up 7.6% After New DRAM LSA Evaluation With Major Memory Maker

• In December 2025, Veeco Instruments Inc. announced that a leading semiconductor memory company had begun evaluating its laser spike annealing system within an advanced DRAM R&D group, a move that extends Veeco’s reach into DRAM and high bandwidth memory applications.
• This one-year evaluation, with potential follow-on orders from 2027 onward, highlights how Veeco’s high-temperature, reduced-thermal-budget LSA technology could become increasingly relevant as AI-driven demand for advanced memory grows toward a projected HBM market of about US$100.00 billion by 2030.
• We’ll now examine how this LSA evaluation for advanced DRAM and HBM might reshape Veeco’s existing investment narrative and risk-reward profile.

Uncover the next big thing with financially sound penny stocks that balance risk and reward.

Veeco Instruments Investment Narrative Recap

To own Veeco, you need to believe that its differentiated process tools can win a meaningful role in advanced AI-driven memory and logic manufacturing, despite recent earnings pressure and valuation questions. The DRAM R&D evaluation is encouraging for the longer term, but it does not change that the key near term catalyst is broader adoption of Veeco’s laser annealing and packaging tools, while the biggest current risk remains execution in a softer, slower growing revenue backdrop.

The most relevant recent update is Veeco’s Q3 2025 earnings, which showed year on year declines in sales and net income alongside subdued near term guidance. Against that context, the new DRAM and HBM LSA evaluation looks more like an option on future growth than a solution to today’s margin compression and lower net profit.

Yet investors should be aware that weaker recent earnings and lower profit margins could still...

Read the full narrative on Veeco Instruments (it's free!)

Veeco Instruments' narrative projects $782.0 million revenue and $66.0 million earnings by 2028. This requires 3.7% yearly revenue growth and about a $5.4 million earnings increase from $60.6 million today.

Uncover how Veeco Instruments' forecasts yield a $32.75 fair value, a 4% upside to its current price.

Exploring Other Perspectives

Three members of the Simply Wall St Community place Veeco’s fair value between US$12.43 and US$33.50, reflecting wide disagreement on upside. Against that spread, the reliance on stronger AI and high performance computing demand to support growth in advanced packaging and laser annealing tools is a key factor that could shape how the company actually performs over time.

Explore 3 other fair value estimates on Veeco Instruments - why the stock might be worth less than half the current price!

Build Your Own Veeco Instruments Narrative

Disagree with existing narratives? Create your own in under 3 minutes - extraordinary investment returns rarely come from following the herd.

• A great starting point for your Veeco Instruments research is our analysis highlighting 1 key reward and 2 important warning signs that could impact your investment decision.
• Our free Veeco Instruments research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Veeco Instruments' overall financial health at a glance.

Curious About Other Options?

Markets shift fast. These stocks won't stay hidden for long. Get the list while it matters:

• Find companies with promising cash flow potential yet trading below their fair value.
• AI is about to change healthcare. These 30 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
• The latest GPUs need a type of rare earth metal called Neodymium and there are only 36 companies in the world exploring or producing it. Find the list for free.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com